Revance Therapeutics, Inc.

Freestone Capital Holdings, LLC

Report date

9/30/2024

Quarter

2024 Q3

Filed

11/14/2024

Shares

18,020

Value ($000)

94

Weight

0.0%

2020 Q4 - 2024 Q3 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q3	11/14/2024	94	0.0%	18,020	9/30/2024
2024 Q1	11/22/2024	89	0.0%	18,020	3/31/2024
2023 Q4	2/13/2024	158	0.0%	18,020	12/31/2023
2023 Q3	11/14/2023	207	0.0%	18,020	9/30/2023
2023 Q2	8/9/2023	456	0.0%	18,020	6/30/2023
2023 Q1	5/12/2023	580	0.0%	18,020	3/31/2023
2022 Q4	2/13/2023	333	0.0%	18,020	12/31/2022
2022 Q3	11/9/2022	817	0.0%	30,256	9/30/2022
2022 Q2	8/9/2022	418	0.0%	30,256	6/30/2022
2022 Q1	5/12/2022	578	0.0%	29,657	3/31/2022
2021 Q4	2/14/2022	484	0.0%	29,657	12/31/2021
2021 Q3	11/15/2021	816	0.0%	29,274	9/30/2021
2021 Q2	8/16/2021	868	0.0%	29,274	6/30/2021
2021 Q1	5/17/2021	818	0.0%	29,274	3/31/2021
2020 Q4	2/16/2021	830	0.0%	29,274	12/31/2020